|
1
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
2
|
Barillari G, Palladino C, Bacigalupo I,
Leone P, Falchi M and Ensoli B: Entrance of the Tat protein of
HIV-1 into human uterine cervical carcinoma cells causes
upregulation of HPV-E6 expression and a decrease in p53 protein
levels. Oncol Lett. 12:2389–2394. 2016.PubMed/NCBI
|
|
3
|
Liu J, Cheng Y, He M and Yao S: Vascular
endothelial growth factor C enhances cervical cancer cell
invasiveness via upregulation of galectin-3 protein. Gynecol
Endocrinol. 30:461–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mordhorst Bohr L, Ahlin C and Sorbe B:
Prognostic impact of the expression of Wnt-signaling proteins in
cervical carcinoma FIGO stage I–IV treated with radiotherapy or
chemoradiotherapy. Oncotarget. 7:63042–63053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai L, Liu D, Lu S, Xu Y and Wang H: The
relationship between gene expression of Forkhead box C2 and tumor
progression in cervical carcinoma. Eur J Gynaecol Oncol.
35:625–630. 2014.PubMed/NCBI
|
|
6
|
Pan J, Yang Q, Shao J, Zhang L, Ma J, Wang
Y, Jiang BH, Leng J and Bai X: Cyclooxygenase-2 induced β1-integrin
expression in NSCLC and promoted cell invasion via the
EP1/MAPK/E2F-1/FoxC2 signal pathway. Sci Rep. 6:338232016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Werden SJ, Sphyris N, Sarkar TR, Paranjape
AN, LaBaff AM, Taube JH, Hollier BG, Ramirez-Peña EQ, Soundararajan
R, den Hollander P, et al: Phosphorylation of serine 367 of FOXC2
by p38 regulates ZEB1 and breast cancer metastasis, without
impacting primary tumor growth. Oncogene. 35:5977–5988. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kume T: The role of FoxC2 transcription
factor in tumor angiogenesis. J Oncol. 2012:2045932012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai J, Wang JY, Yang LL, Xiao Y, Qu ZL,
Qin SH and Ruan QR: Correlation of Forkhead Box C2 with subtypes
and invasive ability of invasive breast cancer. J Huazhong Univ Sci
Techno Med Sci. 34:896–901. 2014. View Article : Google Scholar
|
|
10
|
Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y
and Chen M: Forkhead box protein C2 promotes epithelial-mesenchymal
transition, migration and invasion in cisplatin-resistant human
ovarian cancer cell line (SKOV3/CDDP). Cell Physiol Biochem.
39:1098–1110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bai X, Wang J, Guo Y, Pan J, Yang Q, Zhang
M, Li H, Zhang L, Ma J, Shi F, et al: Prostaglandin E2 stimulates
β1-integrin expression in hepatocellular carcinoma through the EP1
receptor/PKC/NF-κB pathway. Sci Rep. 4:65382014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pietilä M, Vijay GV, Soundararajan R, Yu
X, Symmans WF, Sphyris N and Mani SA: FOXC2 regulates the G2/M
transition of stem cell-rich breast cancer cells and sensitizes
them to PLK1 inhibition. Sci Rep. 6:230702016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You W, Gao H, Fan L, Duan D, Wang C and
Wang K: Foxc2 regulates osteogenesis and angiogenesis of bone
marrow mesenchymal stem cells. BMC Musculoskelet Disord.
14:1992013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sano H, Leboeuf JP, Novitskiy SV, Seo S,
Zaja-Milatovic S, Dikov MM and Kume T: The Foxc2 transcription
factor regulates tumor angiogenesis. Biochem Biophys Res Commun.
392:201–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sekuła M, Miekus K and Majka M:
Downregulation of the CXCR4 receptor inhibits cervical carcinoma
metastatic behavior in vitro and in vivo. Int J
Oncol. 44:1853–1860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Surendran S, Ramegowda SK, Suresh A, Raj
Binil SS, Lakkappa RK, Kamalapurkar G, Radhakrishnan N and Kartha
CC: Arterialization and anomalous vein wall remodeling in varicose
veins is associated with upregulated FoxC2-Dll4 pathway. Lab
Invest. 96:399–408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jang IH, Lu YF, Zhao L, Wenzel PL, Kume T,
Datta SM, Arora N, Guiu J, Lagha M, Kim PG, et al: Notch1 acts via
Foxc2 to promote definitive hematopoiesis via effects on hemogenic
endothelium. Blood. 125:1418–1426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mellor RH, Tate N, Stanton AW, Hubert C,
Mäkinen T, Smith A, Burnand KG, Jeffery S, Levick JR and Mortimer
PS: Mutations in FOXC2 in humans (lymphoedema distichiasis
syndrome) cause lymphatic dysfunction on dependency. J Vasc Res.
48:397–407. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sotiropoulou N, Bravou V, Kounelis S,
Damaskou V, Papaspirou E and Papadaki H: Tumour expression of
lymphangiogenic growth factors but not lymphatic vessel density is
implicated in human cervical cancer progression. Pathology.
42:629–636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fatima A, Wang Y, Uchida Y, Norden P, Liu
T, Culver A, Dietz WH, Culver F, Millay M, Mukouyama YS and Kume T:
Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and
correlates with ERK hyperactivation. J Clin Invest. 126:2437–2451.
2016. View
Article : Google Scholar : PubMed/NCBI
|
